 Nektar Therapeutics NASDAQ:NKTR CFO Gil M. Labrucherie sold 2,000 shares of the firms stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of 19.96, for a total value of 39,920.00. The transaction was disclosed in a filing with the Securities Exchange Commission, which is available at the ... 